Trials / Completed
CompletedNCT05093309
Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Auburn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Objectives: The purpose of this study was to assess the impact of the Empowering Community Pharmacists program on pharmacists' knowledge, perceived barriers, attitudes, confidence, and intentions regarding naloxone services implementation, as well as change in number of naloxone prescriptions dispensed. Methods: A 3-month pragmatic randomized controlled trial was conducted in 2018-2019. Alabama community pharmacists were recruited by email, phone, fax, and mailed postcards and randomized to intervention (monthly resources/reminders + educational webinar) or control (monthly resources/reminders + delayed educational webinar). Outcome measures were assessed via online surveys at baseline (T1), immediately post-intervention (T2), and 3-months post-intervention (T3), including: naloxone knowledge (percent correct); perceived barriers, attitudes, and confidence regarding naloxone services implementation (7-point Likert-type scale, 1=strongly disagree to 7=strongly agree); and number of naloxone prescriptions dispensed. Mean differences between control and intervention groups from T1-T3 were assessed using two-way mixed ANOVA and adjusted analyses were conducted using generalized estimating equations (GEE) with negative binomial distribution (alpha=0.05).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Educational Webinar | At month 1 of the study period, the educational webinar was presented by expert speakers and consisted of 3 modules: 1) naloxone basics; 2) naloxone service implementation strategies; and 3) naloxone recommendation communication strategies. Participants were mailed naloxone nasal spray and auto-injector training devices prior to attending the online webinar so that they could follow along during demonstrations. |
| BEHAVIORAL | Resources | After completing the baseline survey, both control and intervention groups were provided with a basic publicly available flyer about naloxone dosage forms in order to ensure all participants could provide adequate patient care. |
| BEHAVIORAL | Reminders | Reminders consisted of monthly emails from investigators for the purpose of retaining study engagement. |
Timeline
- Start date
- 2018-09-18
- Primary completion
- 2019-09-18
- Completion
- 2019-09-18
- First posted
- 2021-10-26
- Last updated
- 2021-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05093309. Inclusion in this directory is not an endorsement.